The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Roswitha Forstpointner Michael Unterhalt Christiane Pott Hannes Wandt Martin Dreyling Wolfgang Hiddemann |
| Publication date | July 29, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |